A is a graph comparing the occurrence of ischemic stroke and major bleeding (cerebral hemorrhage, intestinal hemorrhage ...
Q: I was recently asked if I take a blood thinner. I wasn’t sure how to answer the question because I occasionally take ...
The cyclooxygenase-2 inhibitors are not antiplatelet drugs. [2] In 1998 only one drug in this class was available, a monoclonal antibody (abciximab) directed against the fibrinogen receptor on the ...
A study from the Karolinska Institutet in Sweden has found that some commonly used cardiovascular medications are linked to a ...
Various clinical, demographic and genetic variables can influence responsiveness to antiplatelet therapy. In 2008, Geisler et al. 10 showed that residual platelet activity in patients with ...
Since the advent of drug-eluting stents, there has been a debate in the intervention community over how long dual antiplatelet therapy should last after PCI. Cardiologists have to carefully ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Guidelines continue to recommend standard dual antiplatelet therapy while endorsing de-escalating therapy and ...
The antiplatelet drug has been recommended for approval by the US regulator's cardiovascular and renal drugs advisory committee, which voted 10-1 in favour. The anticlotting agent would be the ...